Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: A multi-institutional study

HPB

Volumn 12, Issue 1, 2010, Pages 31-36

  Bower, Matthew ^a   Metzger, Tiffany ^a   Robbins, Ken ^b   Tomalty, Dana ^c   Válek, Vlatimil ^d   Boudný, Jean ^d   Andrasina, Tomas ^d   Tatum, Cliff ^e   Martin, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

^b Baptist Health Arkansas   (United States)

^c HUNTSVILLE HOSPITAL   (United States)

^d MASARYK UNIVERSITY   (Czech Republic)

^e Norton Healthcare   (United States)

Author keywords

Chemoembolization; Irinotecan; Liver directed therapy; Metastatic colon cancer

Indexed keywords

CETUXIMAB; IRINOTECAN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BILOMA; CANCER SURGERY; CHEMOTHERAPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG TOLERANCE; FEMALE; HUMAN; LIVER CIRCULATION; LIVER RESECTION; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; METASTASIS; SURGICAL MORTALITY; TREATMENT RESPONSE; TUMOR VOLUME; WOUND INFECTION;

EID: 75449101787     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00117.x     Document Type: Article

References (25)

1. Sjovall A, Jarv V, Blomqvist L, Singnomklao T, Cedermark B, Glimelius B et al. (2004) The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol 30:834-841.
2. Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF et al. (2007) Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 18:1469-1478.
3. Aliberti C, Tilli M, Benea G, Fiorentini G. (2006) Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res 26:3793-3795.
4. Fiorentini G, Aliberti C, Turrisi G, Del Conte A, Rossi S, Benea G et al. (2007) Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In Vivo 21:1085-1091.
5. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al. (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905-914.
6. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK et al. (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23-30.
7. Rothenberg ML, Oza AM, Bigelow RH, Berlin JD, Marshall JL, Ramanathan RK et al. (2003) Superiority of oxaliplatin and fluorouracilleucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 21:2059-2069.
8. Chen HX, Mooney M, Boron M, Vena D, Mosby K, Grochow L et al. (2006) Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301. J Clin Oncol 24:3354-3360.
9. Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC et al. (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution [see comments]. Hepatology 27:1578-1583.
10. Llovet JM, Bruix J. (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-442.
11. Breedis C, Young C. (1954) The blood supply of neoplasms in the liver. Am J Pathol 30:969-975.
12. Lewis AL, Gonzalez MV, Lloyd AW, Hall B, Tang Y, Willis SL et al. (2006) DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335-342.
13. Taylor RR, Tang Y, Gonzalez MV, Stratford PW, Lewis AL. (2007) Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30:7-14.
14. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430.
15. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX et al. (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100:698-711.
16. Couinaud C. (1957) Le Foi: Etudes Anatomogiques et Chirugicales. Paris: Masson.
17. Martin RC, Edwards MJ, McMasters KM. (2004) Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg 188:714-721.
18. Martin RC, Scoggins CR, McMasters KM. (2007) Microwave hepatic ablation: initial experience of safety and efficacy. J Surg Oncol 96:481-486.
19. Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R et al. (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197:233-241.
20. Martin RC, Edwards MJ, McMasters KM. (2004) Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg 188:714-721.
21. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107:459-465.
22. Brown DB, Geschwind JF, Soulen MC, Millward SF, Sacks D. (2006) Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 17:217-223.
23. Herrmann KA, Waggershauser T, Sittek H, Reiser MF. (2000) Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology 215:294-299.
24. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S et al. (2002) Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol 20:1499-1505.
25. Tang Y, Taylor RR, Gonzalez MV, Lewis AL, Stratford PW. (2006) Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. J Control Release 116:e55-e56.